We are live on ! Find out more
CMIIU

CM Life Sciences II Inc. Unit
CMIIU

Delisted

CMIIU was delisted on the 1st of September, 2021.

Back to rankings

58 hedge funds and large institutions have $290M invested in CM Life Sciences II Inc. Unit in 2021 Q1 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+58
Holders Change %
–
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
58
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
SB Management
United Arab Emirates
+$34.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$21.4M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$15.7M
4
PA
Perceptive Advisors
New York
+$15.7M
5
PVI
Pura Vida Investments
New York
+$13M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
SB Management
United Arab Emirates
$35M +$34.3M +2,732,000 New
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$21.8M +$21.4M +1,703,300 New
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$16M +$15.7M +1,250,000 New
PA
4
Perceptive Advisors
New York
$16M +$15.7M +1,250,000 New
PVI
5
Pura Vida Investments
New York
$13.3M +$13M +1,037,863 New
WMSA
6
Weiss Multi-Strategy Advisers
New York
$12.8M +$12.6M +1,002,609 New
TCIM
7
TOMS Capital Investment Management
New York
$11.9M +$11.6M +926,978 New
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$10.2M +$10M +800,000 New
PTC
9
Petrus Trust Company
Texas
$10.2M +$10M +800,000 New
SHCM
10
Sachem Head Capital Management
New York
$10.2M +$10M +800,000 New
GS
11
Gagnon Securities
New York
$9.76M +$9.57M +762,450 New
IM
12
Islet Management
New York
$8.96M +$8.79M +700,000 New
Blackstone Inc
13
Blackstone Inc
New York
$7.68M +$7.53M +600,000 New
DM
14
Deerfield Management
New York
$7.68M +$7.53M +600,000 New
Millennium Management
15
Millennium Management
New York
$7.39M +$7.24M +577,000 New
Morgan Stanley
16
Morgan Stanley
New York
$6.4M +$6.28M +500,252 New
DCM
17
Driehaus Capital Management
Illinois
$6.4M +$6.28M +500,000 New
BCP
18
Berylson Capital Partners
Massachusetts
$4.92M +$4.82M +384,164 New
KC
19
Kepos Capital
New York
$4.74M +$4.65M +370,200 New
GA
20
Gagnon Advisors
New York
$4.7M +$4.6M +366,905 New
SC
21
Samlyn Capital
New York
$4.62M +$4.53M +361,002 New
BCM
22
BlueCrest Capital Management
Jersey
$4.48M +$4.39M +350,000 New
MCM
23
Moore Capital Management
New York
$4.48M +$4.39M +350,000 New
APM
24
Avidity Partners Management
Texas
$4.31M +$4.23M +336,700 New
DC
25
Dendur Capital
New York
$3.84M +$3.77M +300,000 New
1
2 3

CMIIU Hedge Fund Activity: Q1 2021 in Review

58 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences II Inc. Unit (CMIIU) for Q1 2021, worth a combined $290M.

Buyers outnumbered sellers: 58 funds opened new CMIIU positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was SB Management, opening a new position worth an estimated $34.3M.

  • 58 institutional investors held CM Life Sciences II Inc. Unit (CMIIU) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $290M of CM Life Sciences II Inc. Unit stock for Q1 2021.
  • 58 funds opened new CM Life Sciences II Inc. Unit positions in Q1 2021 and 0 closed out, a net change of +58 holders.
  • The largest CM Life Sciences II Inc. Unit buyer in Q1 2021 was SB Management, an estimated $34.3M added.

Based on aggregated 13F filings for Q1 2021.